Metsera has several potential big winners in its pipeline, but the most promising might be its experimental obesity drugs MET ...

A competitive drug market strongly encourages companies to best their rivals by developing the next generation of life-saving therapies.

The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing ...

The weight loss market has become one of the hottest areas in the pharmaceutical industry. Investors looking to capitalize on ...

If you visit a fast-food chain in the next few years, expect the menu to look a little less gluttonous. In between the usual ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it has started selling higher doses ...

Doctors warn that microdosing copycat Ozempic and other GLP-1s is not approved for people with low BMIs and carries risks of ...